Company / Total Assets
BeOne Medicines Ltd. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$8.2B
FY2025
5-year range
$5.8B / $8.5B
FY2021-FY2025
Trend
+38.3%
vs FY2024
Sector context
#23 of 214
Health Care
What the data says
BeOne Medicines Ltd.'s total assets of $8.2B is higher than 89% of companies in the Health Care sector (FY2025). Total Assets has fluctuated over the past 10 years, ranging from $406M in FY2016 to $8.5B in FY2021.
Based on SEC 10-K filings.
$8.2B in FY2025 with a 5-year CAGR of +7.9%. Top quartile in the Health Care sector.
Improved from $5.8B to $8.2B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +8.7%
- 5-Year CAGR
- +7.9%
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 214This company $8.2B Sector average $7.5B
▼
+9.6% above sector average
Key checks
Key Insights
- 5-year CAGR of +7.9%, indicating consistent growth.
- In FY2025, total assets increased 38.3% year-over-year.
- Ranks #23 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.2B | +38.3% |
| FY2024 | $5.9B | +2.0% |
| FY2023 | $5.8B | -9.0% |
| FY2022 | $6.4B | -25.3% |
| FY2021 | $8.5B | +52.4% |
| FY2020 | $5.6B | +247.4% |
| FY2019 | $1.6B | -28.3% |
| FY2018 | $2.2B | +115.0% |
| FY2017 | $1.0B | +157.9% |
| FY2016 | $405.8M | +247.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026